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QUANTITATIVE ANALYSIS OF
HYPERAUTOFLUORESCENT RINGS TO
CHARACTERIZE THE NATURAL HISTORY
AND PROGRESSION IN RPGR-
ASSOCIATED RETINOPATHY
JAMES J. L. TEE, MBBS, FRCOPHTH,*† ANGELOS KALITZEOS, PHD,*† ANDREW R. WEBSTER, MD,
FRCOPHTH,*† TUNDE PETO, MD, PHD,*†‡ MICHEL MICHAELIDES, MD, FRCOPHTH*†
Purpose: Quantitative analysis of hyperautoﬂuorescent rings and progression in
subjects with retinitis pigmentosa associated with retinitis pigmentosa GTPase regulator
(RPGR) gene mutations.
Methods: Prospective observational study of 46 subjects. Ring area, horizontal and
vertical diameter measurements taken from outer and inner ring borders. Intraobserver
repeatability, baseline measurements, progression rates, interocular symmetry, and
association with age and genotype were investigated.
Results: Baseline ring area was 11.8 ± 13.4 mm2 and 11.4 ± 13.2 mm2 for right and left eyes,
respectively, with very strong interocular correlation (r = 0.9398; P , 0.0001). Ring area con-
striction was 1.5 ± 2.0 mm2/year and 1.3 ± 1.9 mm2/year for right and left eyes, respectively, with
very strong interocular correlation (r = 0.878, P, 0.0001). Baseline ring area and constriction rate
correlated negatively with age (r = 20.767; P , 0.0001 and r = 20.644, P , 0.0001, respec-
tively). Constriction rate correlated strongly with baseline area (r = 0.850, P , 0.0001). Age, but
not genotype, exerted a signiﬁcant effect on constriction rates (P , 0.0001), with greatest rates
of progression seen in younger subjects. An exponential decline overall was found.
Conclusion: This study provides disease-speciﬁc baseline values and progression rates
together with a repeatability assessment of fundus autoﬂuorescence metrics. Our ﬁndings can
guide future treatment trials and contribute to the clinical care of patients with RPGR-associated
retinitis pigmentosa.
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Retinitis pigmentosa (RP) as a collection of geneti-cally diverse disorders is a common form of retinal
degeneration with a prevalence of 1:3,000; with 30% to
40% of cases inherited through an autosomal dominant
(AD) route, 45% to 60% through an autosomal recessive
(AR) route, and 5% to 15% as an X-linked trait.1–6
Three quarters of X-linked RP (XLRP) can be attrib-
uted to mutations arising within the retinitis pigmentosa
GTPase regulator (RPGR) gene.6–8 RPGR-associated
retinopathy is especially severe, as characterized by
early disease onset in childhood and fast progression.9
Fundus autoﬂuorescence (FAF) is an established
modality for studying retinal structure (and indirectly
function) in vivo in RP.10–24 The FAF signal is
believed to be derived predominantly from accumula-
tion of lipofuscin/related metabolites in the retinal pig-
ment epithelium25 secondary to photoreceptor outer
segment phagocytosis.26 Increased lipofuscin levels
have been correlated with photoreceptor loss.27 The
presence of abnormally high FAF signal intensity in
surviving areas of retina where metabolic activity is
high and low or absent signals in regions of outer
retinal atrophy has been demonstrated in RP.10,28 Spe-
ciﬁcally, a parafoveal ring of hyperautoﬂuorescence
that constricts over time is evident in patients with
RP.13,15–20,24 Ring size has been correlated with retinal
function as determined by static and kinetic perimetry,
microperimetry, and electrophysiological testing (pattern
ERG P50 and multifocal ERG amplitudes), with greater
preservation of visual function seen in eyes with larger
rings.11–15,22,23 Retinal sensitivity has been found to be
relatively well preserved within the ring and conversely
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low or absent in retinal locations outside the ring.12,19,21,22
Thus, FAF imaging in RP has been demonstrated to be
related to visual function and can thereby indirectly pro-
vide information regarding macular function. Importantly,
this high-signal ring has structural correlates with the
inner border of the ring delineating the limits of a rela-
tively intact ellipsoid zone on spectral domain optical
coherence tomography.15–17,19–22
The lack of RPGR-associated retinopathy-speciﬁc nat-
ural history data hampers current efforts to predict factors
that may guide both recruitment of suitable candidates for
upcoming gene therapy trials and deﬁning which modal-
ities are most suitable for assessing structural measures of
success in these trials. Most aforementioned data were
derived from RP patients without an established genotype
and thereby inherently limit the generalizability of such
results. We herein investigate the suitability of FAF-
derived metrics in determining baseline characteristics
and disease progression in a cohort of molecularly proven
RPGR subjects. We have explored and quantiﬁed the
following: 1) incidence of FAF rings; 2) baseline meas-
urements of FAF rings; 3) suitability and reliability of
a broad range of FAF-derived ring metrics in ring quan-
tiﬁcation; 4) change in ring metrics over time; 5) inter-
ocular symmetry of baseline measurements and
progression rates; 6) association between baseline ring
size and age; 7) associations between progression rates
and a) age, b) baseline ring metrics, and c) genotype.
Patients, Methods, and Statistical Analysis
Ethical approval was granted by the ethics commit-
tee at Moorﬁelds Eye Hospital for this prospective
observational study that is supplemented with FAF
images collected prospectively during routine clinical
care. Adherence to the Declaration of Helsinki was
observed throughout the study. In addition to 33
subjects with bilateral rings who are participants in
our on-going RPGR prospective natural history study,
an additional 13 subjects were identiﬁed through
searching the Moorﬁelds Inherited Eye Disease Data-
base. All subjects were affected males with RP asso-
ciated with likely disease-causing variants in RPGR.
Detailed inclusion and exclusion criteria are provided
in Figure 1.
All images were acquired by dedicated ophthalmic
photographers with either the Spectralis Heidelberg
Retina Angiograph (HRA) +OCT device (Heidelberg
Engineering, Heidelberg, Germany) or Spectralis
HRA2 device (Heidelberg Engineering). A 488-nm
excitational wavelength laser and a barrier ﬁlter of
500 nm were used for imaging. Images were acquired
in either 30°, 35°, or 55° ﬁeld of view as deemed
appropriate at time of imaging. Image analysis with
vendor software (Heidelberg Eye Explorer Region
Finder version 2.4.3.0) was subsequently performed
for each FAF image with the following methods:
1) The outer ring border was ﬁrst delineated in an
ellipsoid shape and ring area obtained from the software,
as shown in Figure 2. 2) The Early Treatment Diabetic
Retinopathy Study grid was next placed onto the foveal
center of the image, as deﬁned by the darkest central spot
within the hypoﬂuorescent foveal center. The grid was
then adjusted clockwise or anticlockwise to compensate
for image rotation, so that its horizontal meridian corre-
sponded to the true horizontal meridian of the fundus
image (as determined by the extrapolation of a straight
line running from the middle of the optic disk to the
foveal center). After adjustment for image rotation, the
outer border horizontal diameter was measured—taken
from bisecting points of the temporal outer ring border
and horizontal grid meridian from one end, passing
through the foveal center, and terminating at the bisect-
ing points nasally (Figure 2). The outer border vertical
diameter measurement was then taken, from superior to
inferior bisecting points (Figure 2). 3) This method was
subsequently repeated for inner border–derived meas-
urements, by delineating the inner ring border to obtain
inner ring area. 4) Horizontal and vertical diameter
measurements running from the inner border through the
foveal center were then made based on the same tech-
nique as described above for outer border metrics.
The most recent image for each eye of all subjects
was measured twice by a single observer, a minimum
of 1 week apart and in random order of the images, to
assess the level of intraobserver repeatability. Meas-
urements were kept apart by laterality and only one
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image per eye per subject was used to maintain the
“independence-of-scores” and to avoid inducing sys-
tematic bias. Calculation of mean ± SD of within-pair
differences and 95% limits of agreement (LOA) were
performed with the Bland–Altman method. Repeat-
ability coefﬁcients and test–retest variability for all
ring metrics were calculated and these are provided in
Table 1, together with corresponding mean overall
annual constriction rates for each metric that were
calculated from rates of individual subjects as
described: all ring metrics measurements (outer and
inner border–derived ring area, horizontal and vertical
diameters) were plotted on scatter plots as a function
of age for each subject, with right eyes kept separate
from left eyes. Rates of constriction for each metric for
each eye of each subject were obtained from gradients
of individual trendlines ﬁtted to data points using
a least squares method (Microsoft Excel for Mac
version 15.24). Figure 3 provides an example of
trendlines for individual subjects ﬁtted to data from
outer border–derived ring area measurements of right
eyes.
Statistical analysis was performed with XLSTAT
version 18.07 software (Addinsoft, New York, NY).
Data are expressed as mean values, with SD and 95%
conﬁdence intervals provided were stated. Data were
inspected for normality with log10 transformation per-
formed before conducting tests of statistical analyses.
Fig. 1. Flowchart illustrating
recruitment of subjects based on
the inclusion and exclusion
criteria.
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Interocular differences in baseline ring size quantiﬁed
with outer border metrics were assessed for signiﬁcance
with the two-tailed paired-samples t-test. Pearson’s cor-
relation coefﬁcient was calculated to investigate interoc-
ular associations of symmetry. Interocular differences in
constriction rates derived from outer border metrics were
also investigated with the two-tailed paired-samples t-test
and Pearson’s correlation coefﬁcient.
After this, data from right and left eyes were
combined for further analyses. Associations between
constriction rates about with respect to baseline
measurements and age were investigated with Pear-
son’s correlation coefﬁcient.
A two-way analysis of variance (ANOVA) was
performed to investigate the effects of age, genotype,
and the interaction of both factors on constriction
rates. Genotype was divided into 2 categories depend-
ing on RPGR sequence variant position: Exon 1 to 14
or Open Reading Frame 15 (ORF15) variants. Age
was divided into 5 categories: Category 1 = ,10 years
of age, Category 2 = 10 to,15 years, Category 3 = 15
to ,20 years, Category 4 = 20 to ,25 years, and
Category 5 = 25 years of age and above. Post hoc
multiple pairwise comparisons were performed with
Tukey’s test in instances of a signiﬁcant ANOVA
result. Signiﬁcance level alpha for statistical tests
was set at 0.0167 after Bonferroni correction, as tests
were simultaneously conducted on 3 ring metrics.
Results
Cohort Characteristics
Ninety-six subjects with FAF imaging were identi-
ﬁed in total, of which 46 possessed bilateral rings, as
shown in Figure 1. In addition, 38 subjects had a cen-
tral hyperautoﬂuorescence pattern in the absence of
rings in one or both eyes, and 12 subjects had a central
hypoautoﬂuorescence pattern in the absence of rings in
one or both eyes. The age of subjects (mean ± SD,
given in years) in the 3 aforementioned FAF groups
are 16.3 ± 7.9 for the bilateral rings group, 35.1 ± 8.8
for the central hyperautoﬂuorescence group, and 53.7
± 12.2 for the central hypoautoﬂuorescence group.
Subject age was calculated from birth to time of base-
line FAF image acquisition. The proportion of subjects
with bilateral rings distributed in respective age cate-
gories are as follows: 19.6% in age Category 1; 17.4%
in age Category 2; 30.4% in age Category 3; 13.0% in
age Category 4; and 19.6% in age Category 5. A total
of 19 of the 46 subjects with bilateral rings harbored
mutations in RPGR exons 1 to 14 and 27 in ORF15.
Forty of the 46 subjects had follow-up imaging
performed. Mean follow-up period was 49.1 ± 31.2
months (range from 9.1 to 141.6 months). Subjects
were followed at variable time intervals. Thirty-four
subjects had$20 months of FAF follow-up, 5 subjects
with 12 months’ follow-up, and 1 with follow-up of
9 months. Most subjects (33/40) underwent three or
more FAF observations during their follow-up period.
Of the 40 subjects with follow-up, a median of 4 FAF
observations per subject (range from 2 to 8 observa-
tions) giving rise to a total of 168 FAF observations
overall were completed.
Metric Repeatability
The results of intraobserver variability assessment
and mean annual rates of constriction for each metric
are provided in Table 1. It can be seen that variability
is least for outer border metrics. Hence, baseline meas-
urements and constriction rates described henceforth
are those derived from the outer border.
Baseline Outer Border Ring Metrics and
Constriction Rates
Baseline outer border ring measurements for both
eyes of all 46 subjects with corresponding P values
from interocular comparisons are provided in Table 2.
Differences in mean of right and left eyes for all outer
border metrics were not statistically signiﬁcant, and all
three metrics were very strongly correlated at baseline
with r $ 0.9310 and P , 0.0001.
Fig. 2. FAF image of the right eye of a subject with superimposed
Early Treatment Diabetic Retinopathy Study grid centered on the fovea
with anticlockwise adjustment of the vertical and horizontal meridians.
Ring area was 13.17 mm2, horizontal diameter was 4,350 mm, and
vertical diameter was 3,971 mm. All measurements in this example were
obtained from the outer border.
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Table 1. Repeatability Indices Derived From Repeated Measurements of Most Recent FAF Images for Each Subject
Outer Border
Metrics
Ring Area Horizontal Diameter Vertical Diameter
Right Eyes Left Eyes Both Eyes Right Eyes Left Eyes Both Eyes Right Eyes Left Eyes Both Eyes
Mean ± SD
of intraobserver
within-pair difference*
0.10 ± 0.46 0.11 ± 0.56 0.11 ± 0.51 65 ± 151 34 ± 153 49 ± 152 37 ± 133 58 ± 151 48 ± 142
95% LOA* 20.80 to 1.00 20.99 to 1.21 20.89 to 1.11 2231 to 361 2266 to 334 2249 to 347 2224 to 298 2238 to 354 2230 to 326
Repeatability coefﬁcient 0.90 1.10 1.00 296 300 298 261 296 278
Test–retest variability (%) 10.78 13.51 12.12 9.09 9.35 9.22 10.33 11.77 11.03
Mean overall annual rate of
constriction (%)
11.25 10.04 10.65 5.87 5.05 5.46 6.74 5.85 6.29
Inner Border
Metrics
Ring Area Horizontal Diameter Vertical Diameter
Right Eyes Left Eyes Both Eyes Right Eyes Left Eyes Both Eyes Right Eyes Left Eyes Both Eyes
Mean ± SD
of intraobserver
within-pair difference*
0.00 ± 0.45 20.16 ± 0.84 20.08 ± 0.68 212 ± 197 252 ± 200 232 ± 199 14 ± 123 231 ± 139 29 ± 133
95% LOA* 20.88 to 0.88 21.81 to 1.49 21.41 to 1.25 2398 to 374 2444 to 340 2422 to 358 2227 to 255 2303 to 241 2270 to 252
Repeatability coefﬁcient 0.88 1.65 1.33 386 392 390 241 272 261
Test–retest variability (%) 20.51 39.86 31.52 17.86 18.86 18.40 14.29 16.27 15.54
Mean overall annual rate of
constriction (%)
12.97 13.23 13.10 7.67 7.75 7.71 7.20 8.06 7.64
Mean overall annual rate of constriction for each metric is provided for comparison.
*Units of measurements are millimeter square for ring area and micrometer for horizontal and vertical diameters.
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Constriction rates of all ring metrics for each eye of
individual subjects were obtained from gradients of
linear trendlines as described in the Methods section.
In general, linear equations provided the best ﬁt. Fig-
ure 3 provides an example of trendlines ﬁtted for each
subject. By contrast, Figure 4 shows ring area measure-
ments of all subjects collectively plotted against age.
When viewed jointly, the change in area approximates
an exponential decline, as conﬁrmed by an exponential
equation being the best ﬁt in this instance with an R2 of
0.6867 and 0.6235 for right eyes and left eyes, respec-
tively. The equation for right eyes is given by y = 50.339
e20.116t and for left eyes, y = 43.742 e20.110t, where y
represents ring area in millimeter square and t represents
age in years. The rate constant, k, for right eyes is 0.116
and 0.110 for left eyes. Half-lives calculated for right
eyes and left eyes are 5.98 and 6.30 years, respectively.
Mean constriction rates, together with results from
investigations of interocular differences are provided
in Table 3. Differences in constriction rates were insig-
niﬁcant for all three ring metrics. Correlation between
constriction rates for right and left eyes was strong and
signiﬁcant for rates derived from vertical diameter
measurements (r = 0.6176, P , 0.0001) and stronger
for rates derived from ring area measurements (r =
0.8779, P , 0.0001). Figure 5 illustrates mean
Fig. 3. Linear trendlines illus-
trating the progression rates of
individual subjects. In this
example, the metric used was
ring area measurements, derived
from the outer borders of sub-
jects’ right eyes.
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constriction rates of right and left eyes of subjects in
the various age categories. Constriction rates across all
three ring metrics were greatest for the youngest age
category.
Baseline and Constriction Rate Associations
After these aforementioned evaluations, data from
right and left eyes were combined for further analyses.
The association between constriction rates with base-
line measurements and age is shown in Table 4. Ring
size at baseline as quantiﬁed with all three outer border
metrics correlated negatively and strongly with age
(r $ 20.7674, P , 0.0001 for all 3). Correlation
between constriction rates and baseline size for each
of the three metrics was found to be strongest for the
area-derived (r = 0.8502, P , 0.0001) and vertical
diameter–derived metrics (r = 0.5969, P , 0.0001).
Correlation for the horizontal diameter–derived metric
was also signiﬁcant, albeit weaker (r = 0.3554, P =
0.0012). In addition, area-derived constriction rates
showed the strongest negative correlation with age
(r = 20.6436, P , 0.0001), whereas that of vertical
diameter rates were moderate in strength (r =
20.4145, P = 0.0001).
A two-way ANOVA was performed to investigate
the effects of age, genotype, and interaction between
age and genotype on constriction rates. Analysis of
variance results together with mean ± SD values for
constriction rates in each category are given in Table
5. The effect of age was signiﬁcant for constriction
rates derived from ring area (P , 0.0001) and vertical
diameter (P = 0.0002). Post hoc pairwise comparisons
between age categories for area-derived constriction
rates disclosed signiﬁcant differences between youn-
ger and older subjects, that is, age Category 1 (youn-
gest) versus all other age categories (P , 0.0001);
Category 2 versus Category 5 (P = 0.0072); and Cat-
egory 3 versus Category 5 (P = 0.0030). Similar ﬁnd-
ings were made with post hoc pairwise comparisons
for vertical diameter–derived constriction rates, in that
differences between Category 1 versus Category 5
(P = 0.0002) and Category 1 versus Category 4 (P =
0.0064) reached statistical signiﬁcance. The effect of
genotype on constriction rates, by contrast, was
insigniﬁcant.
Discussion
In this article, we present the ﬁrst comprehensive
FAF study to describe bilateral progression of
disease in a cohort comprising entirely of molecu-
larly proven subjects with RPGR-associated RP.
Forty-eight percent of subjects in our study had
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rings, in comparison with 55% to 69% described in
other RP cohorts.15,19,23,24,29 Our subjects with
rings are younger in age (16.3 ± 7.9 years of age at
time of baseline imaging) in comparison with mean
ages of 35 to 49 years described in previous
studies.12,18,22,23,29 However, these studies were
composed of subjects with both ADRP and ARRP
and thereby are genetically diverse, with the possible
exception of a study investigating Usher syndrome
Type I and II—although these are also genetically
heterogeneous.19 Only one study included subjects
with molecularly conﬁrmed XLRP—even then com-
prising only 6% of the entire cohort.24 It is therefore
unsurprising that ring ﬁndings (including lack/loss
of an FAF ring in older subjects) and other FAF
observations that signify more advanced disease at
a younger age have been identiﬁed in our cohort of
molecularly proven RPGR RP subjects, as it is rela-
tively more severe with faster progression compared
with other genotypes.
Correlation Between Age and
Baseline Measurements
We found strong and signiﬁcant negative correla-
tions between age and baseline measurements for all
three outer border ring metrics (r $ 20.7674, P ,
0.0001 for all 3 metrics). Our ﬁndings substantiate
weaker associations previously reported between age
and ring size in cohorts of mixed inheritance.12,17,30 In
Fig. 4. Scatter plot of ring area
measurements derived from the
outer border for right and left
eyes of all subjects, plotted col-
lectively against age. An expo-
nential decline is evident.
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addition, numerical age can arguably serve as a good
approximation for disease duration in RPGR RP given
the early onset of disease in childhood typical for the
condition.9
Progression Rates
The progression rates described in our study reﬂect
our cohort of molecularly proven RPGR subjects, which
overall renders a greater disease severity. This is in
contrast with previous studies where cohorts compose
of subjects with mixed inheritance and RP of lesser
severities. Thus, our mean annual area of autoﬂuores-
cence constriction rate of 1.42 mm2 (10.7%), mean
annual horizontal and vertical diameter constriction
rates of 214.1 mm (5.5%) and 207.9 mm (6.3%), respec-
tively, are greater than previously reported.17–19,24 One
recent study of 71 subjects where two-thirds had
ARRP, 27% with ADRP, and only 6% with XLRP
found mean annual constriction rates of 147 mm
(4.1%) and 121 mm (4.0%) for horizontal and vertical
diameter outer border ring metrics, respectively.24 A
study comprising 8 eyes with ADRP and 6 with ARRP
(with no XLRP subjects) reported lower annual outer
ring rates of constriction of 2.5% and 2.1% for horizon-
tal and vertical diameters, respectively.18 A mean
annual ring constriction rate of 60 mm (3.0%) calcu-
lated from outer border ring radius measurements (4.0%
with inner border ring radius) was found in 13 patients
with Usher syndrome.19 Robson et al described 30 RP
subjects with a mixed mode of inheritance who under-
went serial FAF imaging with a mean follow-up of 4
years from baseline. Progression was seen in 17 sub-
jects, 16 of these had ARRP including Usher syndrome,
with a mean annual inner border ring radius constriction
rate of 5.6%.17
Overall Exponential Rate of Decline
To the best of our knowledge, this is the ﬁrst study to
demonstrate an exponential rate of decline in RP on the
basis of serial FAF imaging, with the implication that the
rate of progression decreases with time (Figure 4). Half-
lives of outer border–derived ring area calculated sepa-
rately for right and left eyes are similar at 6 years.
Phenotypic heterogeneity in XLRP-RPGR, however,
necessitates individual observations.9 An exponential
decline has previously been demonstrated in functional
studies,31–33 which were genetically heterogenous with
the exception of Iannaccone et al32 who studied subjects
with Usher syndrome Type II (which nevertheless was
also genetically heterogenous, as subjects were not
genetically conﬁrmed). Massof et al observed that the
visual ﬁeld loss occurred exponentially with a similar
level of decline across all forms of RP, and this was
believed to occur secondary to a common and ﬁnal
process of retinal degeneration. They extrapolated data to
estimate the age at which visual ﬁeld loss began and
hypothesized that any difference was due to the earlier
onset in XLRP.31
We did not set out to directly compare progression
between XLRP-RPGR and other forms of RP in our
study; however, we note that others have found
a greater rate of progression in XLRP. For instance,
Birch et al34 found that the inheritance pattern in RP
had a signiﬁcant effect on progression rates, with
annual rod electroretinogram threshold elevation being
highest in XLRP and lowest in ADRP. Sandberg
et al35 observed a greater annual decline in visual ﬁeld
area in subjects with RPGR-associated RP, compared
with subjects with RHO-associated autosomal domi-
nant RP. A 4.7% mean annual exponential rate of
decline was observed for RPGR-associated RP,
Table 3. Constriction Rates of Each Outer Border Ring Metric for Right and Left Eyes of Subjects
Rate Metric
Right Eyes (n = 40) Left Eyes (n = 40)
P for Paired-
Samples t-
Test
Pearson’s
Correlation
Coefﬁcient, r,
With PMean ± SD 95% CI of Mean Mean ± SD
95% CI of
Mean
Ring area
constriction,
mm2/year
1.50 ± 1.99 0.86–2.14 1.33 ± 1.90 0.72–1.93 0.0703 r = 0.8779,
P , 0.0001
Horizontal
diameter
constriction,
mm/year
234.94 ± 186.89 175.17–294.71 193.19 ± 158.71 142.43–243.95 0.0432 r = 0.4068,
P = 0.0092
Vertical diameter
constriction,
mm/year
225.05 ± 215.02 156.28–293.81 190.73 ± 198.88 127.12–254.33 0.0885 r = 0.6176,
P , 0.0001
Interocular rate differences were assessed for signiﬁcance with the two-tailed paired-samples t-test. Pearson’s correlation coefﬁcient,
r, was calculated to establish associations of interocular symmetry. Statistical analyses with t-test and Pearson’s correlation were
conducted after log10 transformation of variables. Signiﬁcance level alpha was set at 0.0167.
CI, conﬁdence interval.
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compared with 2.9% for RHO-associated RP. Using
structural optical coherence tomography measure-
ments of ellipzoid zone width, Cai et al36 found a sig-
niﬁcantly greater rate of progression in subjects with
XLRP (9.6%/year) compared with ADRP (3.4%/year).
Correlation Between Age and Progression
We found a strong and signiﬁcant negative correlation
between age and rate of area constriction (r = 20.6436,
P , 0.0001). Correlation between age and rate of verti-
cal diameter constriction was moderate (r = 20.4145, P
= 0.0001), whereas correlation between age and horizon-
tal diameter constriction was weak and insigniﬁcant after
Bonferroni correction (r = 20.2366, P = 0.0346). By
contrast, Robson et al17 did not ﬁnd correlation between
age and constriction rates, nor did they ﬁnd correlation
between constriction rates and baseline ring size. Sujir-
akul et al24 also did not ﬁnd differences in constriction
rates with age. Both studies comprised a heterogenous
mix of RP subjects with various forms of inheritance
patterns. This was alluded to as a reason for noncorrela-
tion by Robson et al.17 It is thus possible that potential
correlation with age may have been affected by the aver-
aging of results secondary to the inclusion of subjects
with different forms of RP, given the wide age range of
disease onset and progression rates between different
forms.2
Correlation Between Baseline Ring Metrics
and Progression
Correlation between baseline size with respective
constriction rates was all signiﬁcant and positive. Area
Fig. 5. Mean constriction rates
for ring area, horizontal, and
vertical diameter metrics, for
right and left eyes, of subjects
grouped within respective age
categories. All measurements
were obtained from outer borders
(age categories: 1 = ,10 years of
age, 2 = 10 to ,15 years of age,
3 = 15 to ,20 years of age, 4 =
20 to ,25 years of age, and 5 =
25 years of age and above).
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constriction rate correlated very strongly with base-
line area (r = 0.8502, P , 0.0001), whereas vertical
diameter rate constriction demonstrated a strong cor-
relation with vertical diameter at baseline (r =
0.5969, P , 0.0001). Correlation was weakest for
horizontal diameter (r = 0.3554, P = 0.0012). This
ﬁnding of a signiﬁcant association between larger
baseline measurements and faster progression rates
was also reported by Sujirakul et al24 when the
cohort was divided into subjects with greater or
lesser than a baseline vertical diameter of 3,000 mm.
Interestingly, the association between horizontal diame-
ter constriction and baseline metrics in their study was
not signiﬁcant, in keeping with our ﬁnding of ring hor-
izontal diameter having the weakest correlation of the
three metrics.
Table 4. Associations Between Age With Baseline Measurements, Progression Rates, and Baseline Size With
Progression Rates
Parameters Pearson’s Correlation Coefﬁcient, r P
Age with baseline ring
Area 20.7674 ,0.0001
Horizontal diameter 20.7709 ,0.0001
Vertical diameter 20.7692 ,0.0001
Age with progression rate quantiﬁed
by
Area constriction 20.6436 ,0.0001
Horizontal diameter constriction 20.2366 0.0346
Vertical diameter constriction 20.4145 0.0001
Size at baseline with constriction
rate of
Area 0.8502 ,0.0001
Horizontal diameter 0.3554 0.0012
Vertical diameter 0.5969 ,0.0001
All metrics were derived from the outer border. Pearson’s correlation coefﬁcient was calculated after log10 transformation of all
variables. Signiﬁcance level alpha was set at 0.0167.
Table 5. Results of a Two-Way ANOVA
Area
Constriction Rate
(Mean ± SD), mm2/Year
Horizontal Diameter
Constriction Rate
(Mean ± SD), mm/Year
Vertical Diameter
Constriction Rate
(Mean ± SD), mm/Year
Age categories (n = no. of
eyes)
Category 1 (n = 14) 4.33 ± 2.94 382.88 ± 241.49 449.20 ± 303.81
Category 2 (n = 16) 1.14 ± 0.94 199.97 ± 123.14 188.00 ± 134.03
Category 3 (n = 26) 1.08 ± 0.78 229.02 ± 150.14 211.63 ± 156.76
Category 4 (n = 10) 0.29 ± 0.17 112.97 ± 68.88 73.54 ± 24.59
Category 5 (n = 14) 0.22 ± 0.18 105.80 ± 93.37 78.33 ± 57.29
P (ANOVA) ,0.0001 0.0876 0.0002
Tukey’s test Category 1 vs. all other
categories (P , 0.0001 for
all); Category 2 vs.
Category 5 (P = 0.0072);
and Category 3 vs.
Category 5 (P = 0.0030)
Category 1 vs. Category 4
(P = 0.0064); and Category
1 vs. Category 5
(P = 0.0002)
Genotype
Exon 1–14 (n = 34) 1.41 ± 1.99 198.51 ± 191.50 206.13 ± 240.60
ORF 15 (n = 46) 1.41 ± 1.91 225.56 ± 160.21 209.19 ± 180.04
P (ANOVA) 0.8437 0.7808 0.8653
Age and genotype
interaction
P (ANOVA) 0.2851 0.1097 0.0294
Ring metrics were derived from the outer border.
Signiﬁcance level alpha for ANOVA was set at 0.0167 with analysis performed after log10 transformation of dependent variables. Post
hoc multiple pairwise comparisons were performed using Tukey’s test with 95% conﬁdence levels.
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Effects of Age and Genotype on Progression
The effects of age were signiﬁcant on both ring area
and vertical diameter constriction rates. Post hoc
comparisons showed signiﬁcant differences between
younger subjects, in particular those in age Category 1
compared with older age categories, indicating that
progression is maximal in the youngest subjects. There
was no effect of genotype on constriction rates.
Although speculative in nature, the effects of age
could perhaps be explained by a biochemical model
hypothesized by Clarke et al37 whereby each photore-
ceptor has a risk of death that is constant over time and
occurring at random. In the case of younger subjects with
larger rings, these large rings represent greater numbers
of surviving photoreceptors. It is conceivable that more
photoreceptors will die off at the early stages because of
the greater numbers of photoreceptors present. This
would give rise to a greater initial rate of decline. With
age, as the numbers of surviving photoreceptors
decrease, so will there be a concomitant decrease in
the numbers of photoreceptors dying. Thus, the rate of
decline slows in later age. This model can account for the
exponential graph shown in Figure 4.
Interocular Symmetry
A high level of interocular symmetry at baseline and
for overall rates of progression has been demonstrated
in our study. Interocular symmetry at baseline has also
been reported by others, for example by Robson et al11
who described a strong interocular correlation (r =
0.94) between internal radii of the FAF rings, as well
as symmetry in electrophysiological testing (r = 0.94).
More recently, Sujirakul et al30 also reported good
overall interocular symmetry of vertical and horizontal
diameter ring measures (r = 0.99 and 0.98, respec-
tively). In addition, they did not ﬁnd a difference in
progression rates between eyes.24
Measurement Variability
Wakabayashi et al assessed interobserver variability
for horizontal and vertical ring diameter metrics (not
stated whether these were inner or outer ring measure-
ments) and their coefﬁcient of repeatability was 240
mm for horizontal and 250 mm for vertical diameter.
The 95% LOA was 2230 mm to 270 mm and 2230
mm to 280 mm. Test–retest variability was 14.0% for
horizontal diameter and 20.3% for vertical diameter.16
Three observers in Sujirakul et al measured both
horizontal and vertical outer ring diameters. Limits of
agreement pairs were calculated for each metric by
comparing two observers at a time. The greatest value
from the LOA pairs was used as a cutoff for mea-
surement error, that is, measurements exceeding this
cutoff were deemed clinically signiﬁcant. Here, 421 mm
and 412 mm were the cutoffs for vertical and horizontal
diameter measurements, respectively.30
Sujirakul et al24 also assessed intraobserver variabil-
ity—arguably more important for planned Phase I/II
RP clinical trials. Test–retest variability was 9.5% for
horizontal and 9.6% for vertical outer ring diameter
metric. Annual rate of constriction in their study was
4.1% (147 mm/year) and 4.0% (121 mm/year) for
horizontal and vertical diameter ring metrics, respec-
tively. The 95% LOA calculated from published data
was 2137 mm to 336 mm for horizontal diameter and
2142 mm to 316 mm for vertical diameter metrics. Our
intraobserver variability is comparable, with our test–
retest variability of 9.2% for horizontal diameter and
11.0% for vertical diameter metrics, and 95% LOA of
2249 mm to 347 mm and 2230 mm to 326 mm,
respectively.
These studies solely used ring diameter metrics for
which test–retest variabilities were twice the con-
striction rate.16,24,30 We have identiﬁed ring area
(derived from outer border) to be a robust metric—as
despite a marginally higher test–retest variability when
compared with the diameter metrics, annual rate of
constriction is greatest when quantiﬁed with the area
metric, and approximately of the same magnitude as
its corresponding test–retest variability (Table 1). We
are conﬁdent that constriction rates obtained in our
study are robust and real, as multiple observations with
relatively long follow-up were obtained on our sub-
jects, in addition to the robust method used to derive
constriction rates.
Assessing Suitability by Comparing Annual Mean
Constriction Rates With Largest 95% Limits of
Agreement Value
Mean rate of area constriction for our entire cohort
was 1.42 mm2/year, which is greater than the larger
95% LOA value of 1.11 mm2. In direct contrast, the
mean rate of outer border horizontal diameter constric-
tion was 214.1 mm/year that is smaller than the larger
LOA value of 347 mm. Likewise, vertical diameter
constriction was 207.9 mm/year, which again is small-
er than the larger LOA value of 326 mm. As shown in
Table 5 and Figure 5, constriction rates are greatest in
younger subjects with those in age Category 1 having
a mean area constriction rate of 4.33 mm2/year. Thus,
our ﬁndings of ring area as being the metric of choice
to quantify progression may arguably be even more
sensitive and robust in younger patients with inher-
ently faster rates of progression, who moreover will
likely constitute the target group for intervention.
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Choice of Ring Metrics
Previous groups have used various FAF metrics for
analysis with no apparent consensus. These include
measurements of ring area,15,23 ring horizontal diame-
ter,15,16,18,24 ring vertical diameter,16,18,24,29 and ring
radius.11,12,17,19,22 Others have preferred either measure-
ments taken from the inner borders of the rings15 or from
the outer borders,18,24,30 with the rationale that one bor-
der can be more accurately demarcated over the other. It
is of note that none of these studies have provided results
from objective investigations of measurement repeatabil-
ity to substantiate their preferences. We have undertaken
such assessments for ring and diameter metrics derived
from both borders in our study. Furthermore, none of the
studies that measure diameters on sequential images have
corrected for image rotation, which represents a signiﬁ-
cant limitation.
Conclusion
Our study with a relatively long period of follow-up
has allowed us to obtain sufﬁcient data points to be the
ﬁrst FAF study to demonstrate an overall exponential
decline in progression rate with age. Future studies will
likely require longer periods of follow-up that is, 20
years or more to plot individual exponential decline.
Fundus autoﬂuorescence imaging is reproducible and
widely available in retinal clinics worldwide; hence, we
advocate its regular use in monitoring progression in RP.
Our ﬁnding of outer border–derived ring area as the most
sensitive and valid metric to detect change will guide
metric choice for interventional trials when assessing
disease progression.
In addition, we have presented longitudinal data
using FAF ring metrics to characterize baseline values
and progression rates in RPGR-associated RP. The rate
of progression is dependent on age and baseline ring
size. In general, there is good overall interocular sym-
metry. These ﬁndings will be useful in informing
patient selection and outcome measures in future treat-
ment trials, as well as clinicians providing prognostic
information to patients with RPGR-associated RP.
Key words: fundus autoﬂuorescence, retinal dis-
eases, retinitis pigmentosa, RPGR.
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